FDX vs KROS · P/E 18, rev $94.72B vs rev $32.0K
FedEx Corporation (FDX) versus Keros Therapeutics Inc (KROS) — a side-by-side from cached financials, not a winner call.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
FDX currently screens at market cap $78.98B and trailing P/E 17.7. KROS currently screens at market cap $208.8M.
Not investment advice. Open the FDX and KROS stock pages for the full models.
Not investment advice.